NEOBOROCILLINA C 16PAST S/Z

NEO BOROCILLINA “1,2 MG + 70 MG PASTIGLIE WITH VITAMIN C SENZA ZUCCHERO”

active ingredients

One pastel contains: Active Ingredients: - 2,4 DICLOROBENZIL ALCOOL 1.2 mg. - ASCORBIC ACIDO 70 mg. For the full list of excipients, see 6.1.

Excellent

Mannitolo, polyvinylpyrrolidone K 30, copolyvidone, orange aroma, gliceril beenato, aspartame.

Therapeutic indications

Antiseptic of oropharyngeal cable.

Contraindications

Hypersensitivity to active ingredients or any of the excipients. For the presence of aspartame, the product is contraindicated in case of phenylchetonuria.

Population

Dissolve slowly in the mouth a pastel every 2-3 hours, up to a daily maximum of 8 tablets. Do not exceed the recommended doses.

Conservation

Store at temperature not exceeding 30 ° C.

Warnings

The tablets of Neo Borocillin without sugar contain vitamin C, therefore it must be used with caution by individuals who suffer, or have suffered in the past, of nephrolitiases (renal calculosis) and those suffering from Deficit of G6PD (Glucosio-6-fostato deidrogenasi), hemocromatosis, thalassaemia or sideroblastic anemia. Aspartame This medicine contains 3 mg of aspartame per pastilla. Aspartame is a source of phenylalanine. It can be harmful if it is suffering from phenylchetonuria, a rare genetic disease that causes the accumulation of phenylalanin because the body fails to dispose of it properly. No clinical or non-clinical studies are available on the use of aspartame in children under 12 weeks of age. The product does not contain sucrose, it can therefore be assumed by those who must avoid the administration of such sugar. The use, especially if prolonged, of oral topical products can give rise to awareness. In this case it is necessary to stop the treatment and consult the doctor for the purpose of establishing suitable therapy. After a short period of treatment without appreciable results, consult your doctor. _.

Interactions

Avoid the contemporary use of other antiseptics.

Effects

They were reported very rarely: reactions of hypersensitivity, feeling of head turning, respiratory failure, glottis edema, vomiting, malaise, sweating, edema of the arms, perioral edema, edema of the eyelids, edema of the face, hives, hemolytic anemia, jaundice. Reporting of suspicious adverse reactions. The reporting of suspicious adverse reactions that occur after the authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk ratio of the medicinal product. Healthcare workers are required to report any suspected adverse reaction via the national reporting system at the address https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse.

Overdosing

No overdose cases have been reported. In case of overdosing, appropriate symptomatic treatments must be adopted.

There is no adequate data regarding the use of 2.4-diclorobenzil alcohol and ascorbic acid in pregnant women. In pregnant women and during breastfeeding, the product should be administered in case of actual need and under the direct control of the doctor.

Source: Farmadati